Report overview
This report contains market size and forecasts of Drugs for Vancomycin-Resistant Enterococcus Faecium in Global, including the following market information:
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drugs for Vancomycin-Resistant Enterococcus Faecium market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Daptomycin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs for Vancomycin-Resistant Enterococcus Faecium include Alchemia Limited, Alvogen, Aphios Corporation, Cellceutix Corporation, Enanta Pharmaceuticals, Helix BioMedix, LegoChem Biosciences, Lytix Biopharma and MGB Biopharma Limited and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Vancomycin-Resistant Enterococcus Faecium companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segment Percentages, by Type, 2021 (%)
Daptomycin
Linezolid
Quinupristin/dalfopristin
Ampicillin
Chloramphenicol
Others
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Vancomycin-Resistant Enterococcus Faecium revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drugs for Vancomycin-Resistant Enterococcus Faecium revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix
